Clinical Trial Update: Study Evaluating the Safety and Efficacy of Tigecycline in Hospitalized Patients With cIAI [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating the safety and efficacy of tigecycline for complicated intra-abdominal infection in hospitalized patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Abdominal Abscess
• Complicated Intra-abdominal Infection

Drugs mentioned

• TYGACIL (tigecycline)

Snippet

Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer | Conditions: Abdominal Abscess | Phase 4 | Status: COMPLETED